Literature DB >> 12380702

Advance care planning in Australia: overdue for improvement.

D McD Taylor1, P A Cameron.   

Abstract

As the population of Australia ages, the issue of advance care planning (ACP) to improve medical management towards life's end becomes more important. However, ACP appears poorly developed in Australia. This article discusses ACP and advance directives in the context of the Australian experience and compares this with the experience overseas. It highlights the need for an improvement in ACP and recommends specific areas for discussion and research.

Mesh:

Year:  2002        PMID: 12380702     DOI: 10.1046/j.1445-5994.2002.00268.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  4 in total

1.  Development and evaluation of an aged care specific Advance Care Plan.

Authors:  William Silvester; Ruth A Parslow; Virginia J Lewis; Rachael S Fullam; Rebekah Sjanta; Lynne Jackson; Vanessa White; Rosalie Hudson
Journal:  BMJ Support Palliat Care       Date:  2013-03-15       Impact factor: 3.568

2.  Gender differences in the intention to withhold life-sustaining treatments involving severe dementia for self and on behalf of parent or spouse.

Authors:  Duan-Rung Chen; Jih-Shuin Jerng; Daniel Fu-Chang Tsai; Yuchi Young
Journal:  BMC Palliat Care       Date:  2022-10-06       Impact factor: 3.113

3.  Quality of advance care planning policy and practice in residential aged care facilities in Australia.

Authors:  William Silvester; Rachael S Fullam; Ruth A Parslow; Virginia J Lewis; Rebekah Sjanta; Lynne Jackson; Vanessa White; Jane Gilchrist
Journal:  BMJ Support Palliat Care       Date:  2012-11-15       Impact factor: 3.568

4.  A cost-consequence analysis of normalised advance care planning practices among people with chronic diseases in hospital and community settings.

Authors:  Sarah Jeong; Se Ok Ohr; Peter Cleasby; Tomiko Barrett; Ryan Davey; Simon Deeming
Journal:  BMC Health Serv Res       Date:  2021-07-23       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.